What Researchers Did
Researchers conducted a systematic review to evaluate the efficacy of hyperbaric oxygen therapy (HBOT) as an adjunctive treatment for necrotizing otitis externa (NOE).
What They Found
The review found that hyperbaric oxygen therapy (HBOT) shows promise for necrotizing otitis externa (NOE), with several included studies reporting complete resolution of infection and prevention of recurrence, particularly in refractory cases. While the current evidence is insufficient to establish HBOT as a standard treatment, its potential to improve clinical outcomes and reduce morbidity is considered significant.
What This Means for Canadian Patients
For Canadian patients with refractory necrotizing otitis externa (NOE), hyperbaric oxygen therapy (HBOT) could be a beneficial adjunctive treatment option if hyperbaric facilities are accessible. Patients should discuss with their healthcare providers whether HBOT is appropriate for their specific condition, especially in cases where standard treatments have been ineffective.
Canadian Relevance
This systematic review has no direct Canadian connection or specific data related to Canadian patients or healthcare systems.
Study Limitations
A key limitation is the insufficient high-quality evidence, including a lack of randomized controlled trials, to definitively establish hyperbaric oxygen therapy as a standard treatment for necrotizing otitis externa.